The company has received final approval from the US Food Drug Administration (USFDA) for Calcipotriene and Betamethasone Dipropionate Foam, the generic version of Leo Pharma#39;s Enstilar, Glenmark Pharma said in a statement.
The company has received final approval from the US Food Drug Administration (USFDA) for Calcipotriene and Betamethasone Dipropionate Foam, the generic version of Leo Pharma#39;s Enstilar, Glenmark Pharma said in a statement. The company has received final approval from the US Food Drug Administration (USFDA) for Calcipotriene and Betamethasone Dipropionate Foam, the generic version of Leo Pharma#39;s Enstilar, Glenmark Pharma said in a statement. Moneycontrol Latest News Read More
English 
हिन्दी